On September 2, 2025, the National Administration of Medicines, Food, and Medical Technology (ANMAT) issued Provision 6223/2025, approving the general guidelines for determining inclusion and exclusion criteria for Active Pharmaceutical Ingredients (APIs) covered by the National Drug Traceability System (Annex I).
The regulation was issued in order to address the problem of trade in illegitimate medicines, considering that this represents a serious public health issue.
Access the complete text of the Provision here.
For more information, please contact:
Jorge Muratorio – MuratorioJ@eof.com.ar
Agustín Siboldi – SiboldiA@eof.com.ar
Ana Belen Micciarelli – MicciarelliA@eof.com.ar
Nives Marisa Fornarini Costa – FornariniCostaN@eof.com.ar